Tevogen Bio Holdings, Inc. (TVGN) Q4 2025 Annual Earnings
TVGN·Reported March 31, 2026
Diluted EPS came in at $-1.50 (+42.3% YoY).
Diluted EPS
$-1.50met estimate
Consensus: $-1.50
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about Tevogen Bio Holdings, Inc.'s Q4 2025 earnings report.
Tevogen Bio Holdings, Inc. (TVGN) reported Q4 2025 earnings on March 31, 2026.
Tevogen Bio Holdings, Inc. reported diluted EPS of $-1.50 for Q4 2025.
EPS beat the consensus estimate of $-1.50 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 42.3% from $-2.60.
You can read the 10-K periodic report (0001493152-26-014326) directly on SEC EDGAR. The filing index links above go to sec.gov.